Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Roxiticus Life Sciences Fund is a venture capital investment vehicle focused on the life sciences and healthcare sectors. Managed by its general partner, Solar Centre LLC, the fund provides capital and strategic support to early-stage and growth-stage companies developing innovative medical technologies and therapeutics. The firm is particularly active in identifying high-potential opportunities within the biotechnology and pharmaceutical industries. Its investment strategy leverages the deep industry expertise of its leadership, including former Dendrite International CEO John Bailye, to foster the development of next-generation healthcare solutions. The fund typically targets investments that can benefit from both financial backing and operational guidance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Roxiticus Life Sciences Fund.